BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38627156)

  • 21. Factors associated with lymph node metastasis upstage after resection for patients with micropapillary lung adenocarcinoma.
    Matsushima K; Sonoda D; Mitsui A; Tamagawa S; Hayashi S; Naito M; Matsui Y; Shiomi K; Satoh Y
    Thorac Cancer; 2022 Jan; 13(1):48-53. PubMed ID: 34866323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non-small cell lung cancer.
    Kneuertz PJ; Cheufou DH; D'Souza DM; Mardanzai K; Abdel-Rasoul M; Theegarten D; Moffatt-Bruce SD; Aigner C; Merritt RE
    J Thorac Cardiovasc Surg; 2019 Nov; 158(5):1457-1466.e2. PubMed ID: 31623811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robotic Approach Offers Similar Nodal Upstaging to Open Lobectomy for Clinical Stage I Non-small Cell Lung Cancer.
    Tang A; Raja S; Bribriesco AC; Raymond DP; Sudarshan M; Murthy SC; Ahmad U
    Ann Thorac Surg; 2020 Aug; 110(2):424-433. PubMed ID: 32240644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nodal Upstaging in Robotic and Video Assisted Thoracic Surgery Lobectomy for Clinical N0 Lung Cancer.
    Lee BE; Shapiro M; Rutledge JR; Korst RJ
    Ann Thorac Surg; 2015 Jul; 100(1):229-33; discussion 233-4. PubMed ID: 26037538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer.
    Chu CH; Chiu TH; Wang CC; Chang WC; Huang AC; Liu CY; Wang CL; Ko HW; Chung FT; Hsu PC; Guo YK; Kuo CS; Yang CT
    Thorac Cancer; 2020 Jun; 11(6):1541-1549. PubMed ID: 32281272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
    Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
    Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Factors for Occult Lymph Node Metastasis in Peripheral Non-Small Cell Lung Cancer with Invasive Component Size 3 cm or Less.
    Moon Y; Choi SY; Park JK; Lee KY
    World J Surg; 2020 May; 44(5):1658-1665. PubMed ID: 31912252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nodal Upstaging Is More Common with Thoracotomy than with VATS During Lobectomy for Early-Stage Lung Cancer: An Analysis from the National Cancer Data Base.
    Medbery RL; Gillespie TW; Liu Y; Nickleach DC; Lipscomb J; Sancheti MS; Pickens A; Force SD; Fernandez FG
    J Thorac Oncol; 2016 Feb; 11(2):222-33. PubMed ID: 26792589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk Factors of Nodal Upstaging in Clinical Ia Lung Adenocarcinoma].
    Qin Y; Qiu T; Xuan Y; Zhao Y; Jiao W
    Zhongguo Fei Ai Za Zhi; 2018 Jun; 21(6):463-469. PubMed ID: 29945705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nodal upstaging evaluation in NSCLC patients treated by robotic lobectomy.
    Zirafa C; Aprile V; Ricciardi S; Romano G; Davini F; Cavaliere I; Alì G; Fontanini G; Melfi F
    Surg Endosc; 2019 Jan; 33(1):153-158. PubMed ID: 29943062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophil-Lymphocyte Ratio as a Prognostic Marker for Lung Adenocarcinoma After Complete Resection.
    Takahashi Y; Kawamura M; Hato T; Harada M; Matsutani N; Horio H
    World J Surg; 2016 Feb; 40(2):365-72. PubMed ID: 26493696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis.
    Liao Y; Ni Y; He R; Liu W; Du J
    J Cancer Res Clin Oncol; 2013 Sep; 139(9):1523-8. PubMed ID: 23835897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy.
    Yılmaz U; Ozdemir O; Batum O; Ermin S
    Indian J Cancer; 2018; 55(3):276-281. PubMed ID: 30693894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery.
    Forget P; Machiels JP; Coulie PG; Berliere M; Poncelet AJ; Tombal B; Stainier A; Legrand C; Canon JL; Kremer Y; De Kock M
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S650-60. PubMed ID: 23884751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
    Lyu L; Liu Y; Wang XY; Zhang ZK; Tao XL; Yang L; Wu N
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):441-447. PubMed ID: 31216830
    [No Abstract]   [Full Text] [Related]  

  • 36. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer.
    Schernberg A; Mezquita L; Boros A; Botticella A; Caramella C; Besse B; Escande A; Planchard D; Le Péchoux C; Deutsch E
    PLoS One; 2018; 13(10):e0204490. PubMed ID: 30304046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic Value of Neutrophil-to-lymphocyte Ratio in Patients 
with Lung Adenocarcinoma Treated with Radical Dissection].
    Wang G; Xiong R; Wu H; Xu G; Li C; Sun X; Xie M
    Zhongguo Fei Ai Za Zhi; 2018 Aug; 21(8):588-593. PubMed ID: 30172265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-different extent of resection for clinical IA non-small cell lung cancer: analysis of nodal metastasis.
    Deng HY; Zhou J; Wang RL; Jiang R; Qiu XM; Zhu DX; Tang XJ; Zhou Q
    Sci Rep; 2020 Jun; 10(1):9587. PubMed ID: 32533050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival.
    Veeramachaneni NK; Battafarano RJ; Meyers BF; Zoole JB; Patterson GA
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):466-9. PubMed ID: 18249130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.